BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 3383332)

  • 1. Induction by growth factors from platelets of the focus-forming transformed phenotype in carcinogen-treated C3H/10T1/2 fibroblasts.
    Mordan LJ
    Carcinogenesis; 1988 Jul; 9(7):1129-34. PubMed ID: 3383332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by retinoids of platelet growth factor-dependent stimulation of DNA synthesis and cell division in density-arrested C3H 10T1/2 fibroblasts.
    Mordan LJ
    Cancer Res; 1989 Feb; 49(4):906-9. PubMed ID: 2783558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of PDGF-induced, PKC-independent c-fos expression in a chemically transformed C3H/10T1/2 cell clone.
    Vassbotn FS; Skar R; Holmsen H; Lillehaug JR
    Exp Cell Res; 1992 Sep; 202(1):98-104. PubMed ID: 1380924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
    Bertram JS
    Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the promotion of transformation in chemically-initiated C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
    Frazelle JH; Abernethy DJ; Boreiko CJ
    Carcinogenesis; 1983; 4(6):709-15. PubMed ID: 6861275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible expression of morphological transformation in C3H/10T1/2 mouse embryo cultures exposed to 12-O-tetradecanoylphorbol-13-acetate.
    Sanchez JH; Abernethy DJ; Boreiko CJ
    Carcinogenesis; 1986 Nov; 7(11):1793-6. PubMed ID: 3769129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of methylcholanthrene-"initiated" C3H/10T1/2 cells by inhibiting neoplastic progression with retinyl acetate.
    Mordan LJ; Bergin LM; Budnick JE; Meegan RR; Bertram JS
    Carcinogenesis; 1982; 3(3):279-85. PubMed ID: 7083469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of C3H/10T1/2 cell transformation by N-methyl-N'-nitro-N-nitrosoguanidine and aflatoxin B1.
    Boreiko CJ; Ragan DL; Abernethy DJ; Frazelle JH
    Carcinogenesis; 1982; 3(4):391-5. PubMed ID: 6807561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Okadaic acid inhibits PDGF-induced proliferation and decreases PDGF receptor number in C3H/10T1/2 mouse fibroblasts.
    Dean NM; Mordan LJ; Tse K; Mooberry SL; Boynton AL
    Carcinogenesis; 1991 Apr; 12(4):665-70. PubMed ID: 1849470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of treatment artifact in the effect of cell density upon frequencies of C3H/10T1/2 cell transformation.
    Huband JC; Abernethy DJ; Boreiko CJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6314-21. PubMed ID: 4063983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth state, tumor promoters, and transformation upon intercellular communication between C3H/10T1/2 murine fibroblasts.
    Boreiko CJ; Abernethy DJ; Rickert DE; Stedman DB
    Carcinogenesis; 1989 Jan; 10(1):113-21. PubMed ID: 2910519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and biochemical characterization of cell lines derived from initiation-promotion transformed C3H/10T1/2 cells.
    Male R; Bjerkvig R; Lillehaug JR
    Carcinogenesis; 1987 Oct; 8(10):1375-83. PubMed ID: 3652375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum components in density-dependent inhibition of growth of cells in culture. Platelet-derived growth factor is the major serum determinant of saturation density.
    Vogel A; Ross R; Raines E
    J Cell Biol; 1980 May; 85(2):377-85. PubMed ID: 7372711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells.
    Currie GA
    Br J Cancer; 1981 Mar; 43(3):335-43. PubMed ID: 7225284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a serum-free culture system comparing growth factor requirements of transformed and untransformed cells.
    Mulder KM; Childress-Fields KE
    Exp Cell Res; 1990 Jun; 188(2):254-61. PubMed ID: 2185944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuum of transformed phenotypes in C3H/10T1/2 derivatives.
    Chen AC; Herschman HR
    Carcinogenesis; 1988 Sep; 9(9):1695-700. PubMed ID: 3409475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced neoplastic transformation of stationary phase C3H/10T1/2 cells in response to different dose rates and to post-irradiation treatment with tumor promoter.
    Kolman A; Harms-Ringdahl M
    Chem Biol Interact; 1996 Jun; 101(1):59-69. PubMed ID: 8665619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of DNA synthesis by transient exposure of cell cultures to TPA or polypeptide mitogens: induction of competence or incomplete removal?
    Dicker P; Rozengurt E
    J Cell Physiol; 1981 Oct; 109(1):99-109. PubMed ID: 6460041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro.
    Dainiak N; Davies G; Kalmanti M; Lawler J; Kulkarni V
    J Clin Invest; 1983 May; 71(5):1206-14. PubMed ID: 6853708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the chemotactic response of NIH/3T3 cells to PDGF by growth factors, transformation, and tumor promoters.
    Grotendorst GR
    Cell; 1984 Feb; 36(2):279-85. PubMed ID: 6607119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.